As we enter 2026, we take a moment to reflect on the significant achievements of […]
2025: A Year of Results. 2026: A Year of Opportunity
Currently browsing: News
Camber Specialty Attends ASHP Midyear 2025
Our Specialty Team recently attended the ASHP 2025 Midyear Clinical Meeting and Exhibition, marking a […]
Camber Awarded 2025 “Large Supplier of the Year” by the Premier Group
Camber Pharmaceuticals has been awarded the Premier Group’s 2025 Large Supplier of the Year, presented […]
Camber Launches Imatinib Mesylate Tablets
Camber Pharmaceuticals continues to strengthen its range of treatment options with the introduction of Imatinib Mesylate […]
Focus Generics for December
Camber Pharmaceuticals has one of the fastest-growing portfolios in the U.S. generic drug industry. We […]
Camber Launches Nilotinib Capsules
Camber Pharmaceuticals continues to strengthen its range of treatment options with the introduction of Nilotinib […]
Camber Awarded 2025 Supplier of the Year by OptiSource
Camber Pharmaceuticals was honored and received the 2025 Supplier of the Year award during OptiSource’s […]
Camber Launches Eletriptan Hydrobromide Tablets
Camber Pharmaceuticals continues to strengthen its range of treatment options with the introduction of Eletriptan […]
Camber Launches Abacavir and Lamivudine Tablets, USP
Continuing its mission to expand access to essential treatments, Camber Pharmaceuticals introduces Abacavir and Lamivudine […]
Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
Hetero is one of the world’s leaders in HIV and AIDS medicine Camber Pharmaceuticals’ parent […]